` Comparison: 603883 vs WBA - Alpha Spread

603883
vs
WBA

Over the past 12 months, LBX Pharmacy Chain JSC has underperformed WBA, delivering a return of -6% compared to the WBA's +17% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
603883
WBA
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

LBX Pharmacy Chain JSC Intrinsic Value
HIDDEN
Show
WBA Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
LBX Pharmacy Chain JSC
SSE:603883
14.91 CNY
Walgreens Boots Alliance Inc
NASDAQ:WBA
11.98 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
603883, WBA

603883
WBA
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
LBX Pharmacy Chain JSC
Revenue
Walgreens Boots Alliance Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
603883, WBA

603883
WBA
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
LBX Pharmacy Chain JSC
SSE:603883
Walgreens Boots Alliance Inc
NASDAQ:WBA
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

LBX Pharmacy Chain JSC
31.8%
WBA
17.1%

Operating Margin

LBX Pharmacy Chain JSC
4%
WBA
2.2%

Net Margin

LBX Pharmacy Chain JSC
1.9%
WBA
-4.1%

FCF Margin

LBX Pharmacy Chain JSC
11.4%
WBA
0.4%

ROE

LBX Pharmacy Chain JSC
6.1%
WBA
-60.5%

ROA

LBX Pharmacy Chain JSC
2%
WBA
-8.3%

ROIC

LBX Pharmacy Chain JSC
5%
WBA
7.4%

ROCE

LBX Pharmacy Chain JSC
8.3%
WBA
6.7%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
603883, WBA

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
603883, WBA

Performance Gap Between 603883 and WBA
HIDDEN
Show

Performance By Year
603883, WBA

Loading
603883
WBA
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 603883 to other stocks
CLS
Clicks Group Ltd
C
More expensive
vs LBX Pharmacy Chain JSC
DCP
Dis-Chem Pharmacies Ltd
D
More expensive
vs LBX Pharmacy Chain JSC
9776
Sapporo Clinical Laborat...
More expensive
vs LBX Pharmacy Chain JSC
RADL3
Raia Drogasil SA
More expensive
vs LBX Pharmacy Chain JSC
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett